Which biopsy method finds prostate cancer best? major trial launches

NCT ID NCT06517901

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways to use MRI images during prostate biopsy: software fusion (computer-assisted) and cognitive fusion (doctor's visual estimate). Over 1,300 men with suspicious prostate lesions will be randomly assigned to one method. The goal is to see which technique detects clinically significant prostate cancer more accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If one method proves better, it could become the standard way to diagnose prostate cancer, leading to more accurate detection and fewer unnecessary biopsies.
What could go wrong
This is a diagnostic comparison, not a treatment trial. Even if one method is better, it won't cure or prevent cancer. Results may not apply to all men or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albany Medical Center

    RECRUITING

    Albany, New York, 12208, United States

  • Lahey Clinic, Inc

    RECRUITING

    Burlington, Massachusetts, 01805, United States

  • Manitoba Prostate Centre, CancerCare Manitoba

    NOT_YET_RECRUITING

    Winnipeg, Manitoba, R3A 1M5, Canada

  • Pennsylvania State University

    NOT_YET_RECRUITING

    Hershey, Pennsylvania, 17023, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.